The Effects of Implementing a Mobile Health–Technology Supported Pathway on Atrial Fibrillation–Related Adverse Events Among Patients With Multimorbidity-Reference-Cited by-同舟云学术

The Effects of Implementing a Mobile Health–Technology Supported Pathway on Atrial Fibrillation–Related Adverse Events Among Patients With Multimorbidity

Published:2021-12-21 Issue:12 Volume:4 Page:e2140071
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Yao Yuan¹,Guo Yutao²³,Lip Gregory Y. H.²³⁴,Guo Yutao⁵,Lip Gregory Y H⁵,Lane Deirdre A.⁵,Chen Yundai⁵,Wang Liming⁵,Eckstein Jens⁵,Thomas G Neil⁵,Liu Tong⁵,Feng Mei⁵,Liu Xuejun⁵,Li Xiaoming⁵,Shan Zhaoliang⁵,Shi Xiangming⁵,Zhang Wei⁵,Xing Yunli⁵,Wen Jing⁵,Wu Fan⁵,Yang Sitong⁵,Jin Xiaoqing⁵,Yang Bo⁵,Bai Xiaojuan⁵,Jiang Yuting⁵,Liu Yangxia⁵,Song Yingying⁵,Tan Zhongju⁵,Yang Li⁵,Luan Tianzhu⁵,Niu Chunfeng⁵,Zhang Lili⁵,Li Shuyan⁵,Wang Zulu⁵,Xv Bing⁵,Liu Liming⁵,Jin Yuanzhe⁵,Xia Yunlong⁵,Chen Xiaohong⁵,Wu Fang⁵,Zhong Lina⁵,Sun Yihong⁵,Jia Shujie⁵,Li Jing⁵,Li Nan⁵,Li Shijun⁵,Liu Huixia⁵,Li Rong⁵,Liu Fan⁵,Ge Qingfeng⁵,Guan Tianyun⁵,Wen Yuan⁵,Li Xin⁵,Ren Yan⁵,Chen Xiaoping⁵,Chen Ronghua⁵,Shi Yun⁵,Zhao Yulan⁵,Shi Haili⁵,Zhao Yujie⁵,Wang Quanchun⁵,Sun Weidong⁵,Wei Lin⁵,Chan Esther⁵,Shan Guangliang⁵,Yao Chen⁵,Zong Wei⁵,Chen Dandi⁵,Han Xiang⁵,Xu Anding⁵,Fan Xiaohan⁵,Yu Ziqiang⁵,Gu Xiang⁵,Ge Fulin⁵,

Affiliation:

1. Institute for Hospital Management Research, Chinese PLA General Hospital, Beijing, China

2. Department of Pulmonary Vessel and Thrombotic Disease, Medical School of Chinese PLA, Chinese PLA General Hospital, Beijing, China

3. Liverpool Centre for Cardiovascular Sciences, University of Liverpool, Liverpool Heart & Chest Hospital, Liverpool, United Kingdom

4. Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

5. for the mAF-App II Trial investigators

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2787281/yao_2021_oi_211125_1639430352.60997.pdf

Reference27 articles.

1. Epidemiology of atrial fibrillation: European perspective.;Zoni-Berisso;Clin Epidemiol,2014

2. Comprehensive management with the ABC (Atrial Fibrillation Better Care) pathway in clinically complex patients with atrial fibrillation: a post hoc ancillary analysis from the AFFIRM Trial.;Proietti;J Am Heart Assoc,2020

3. Four-year trends in oral anticoagulant use and declining rates of ischemic stroke among 194,030 atrial fibrillation patients drawn from a sample of 12 million people.;Maggioni;Am Heart J,2020

4. Atrial fibrillation in the United Kingdom: predicting costs of an emerging epidemic recognising and forecasting the cost drivers of atrial fibrillation-related costs.;Burdett;Eur Heart J Qual Care Clin Outcomes,2020

5. Long-term relationship between atrial fibrillation, multimorbidity and oral anticoagulant drug use.;Proietti;Mayo Clin Proc,2019

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atrial fibrillation: epidemiology, screening and digital health;The Lancet Regional Health - Europe;2024-02

2. Atrial fibrillation: comorbidities, lifestyle, and patient factors;The Lancet Regional Health - Europe;2024-02

3. Impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: an analysis from the GLORIA-AF registry;Europace;2023-12-28

4. Potentially inappropriate prescribing in multimorbid and polymedicated older adults with AF: A Systematic Review and Meta-Analysis;Drugs & Aging;2023-11-17

5. Implications of Clinical Risk Phenotypes on the Management and Natural History of Atrial Fibrillation: A Report From the GLORIA‐AF;Journal of the American Heart Association;2023-10-17